BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 10/03/2014

FDA Clears ZEFAZONE (Cefmetazole Sodium) for Approval via Abbreviated New Drug Applications

The FDA has determined that ZEFAZONE (cefmetazole sodium) Injection and IV Solution were not withdrawn from sale due to safety or effectiveness concerns, paving the way for approval of these products through abbreviated new drug applications.

Source: Federal Register — Food and Drug AdministrationOpen original release →